BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2956130)

  • 21. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dexamethasone and clomiphene citrate on peripheral steroid levels and ovarian function in a hirsute amenorrheic patient.
    Chang RJ; Abraham GE
    Fertil Steril; 1976 Jun; 27(6):640-6. PubMed ID: 132375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
    Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
    Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
    Lumachi F; Rondinone R
    Fertil Steril; 2003 Apr; 79(4):942-6. PubMed ID: 12749435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women.
    Meikle AW; Odell WD
    Fertil Steril; 1986 Aug; 46(2):227-31. PubMed ID: 3015694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategic approach of hyperandrogenism in women.
    Tourniaire J; Pugeat M
    Horm Res; 1983; 18(1-3):125-34. PubMed ID: 6309640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women.
    Azziz R; Gay FL; Potter SR; Bradley E; Boots LR
    J Clin Endocrinol Metab; 1991 May; 72(5):1025-30. PubMed ID: 1850751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian and adrenal contributions to peripheral androgens in hirsute women.
    Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
    Obstet Gynecol; 1975 Aug; 46(2):169-73. PubMed ID: 125398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women.
    Glickman SP; Rosenfield RL; Bergenstal RM; Helke J
    J Clin Endocrinol Metab; 1982 Aug; 55(2):251-7. PubMed ID: 6282921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of clinical and hormonal effects in hirsute women treated with ketoconazole.
    Conget JI; Halperin I; Ferrer J; González-Clemente JM; Martinez-Osaba MJ; Vilardell E
    J Endocrinol Invest; 1990 Dec; 13(11):867-70. PubMed ID: 2151039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone, androstenedione, dehydroepiandrosterone sulfate, and sex-hormone-binding globulin in pregnant alcohol abusers.
    Ylikorkala O; Stenman UH; Halmesmäki E
    Obstet Gynecol; 1988 May; 71(5):731-5. PubMed ID: 2965802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are adrenal and testicular androgen levels correlated?
    Georgiadis EI; Matzoros C; Aliferis C; Batrinos M
    Horm Metab Res; 1992 Oct; 24(10):488-91. PubMed ID: 1464416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11 beta-hydroxyandrostenedione: a marker of adrenal function in hirsutism.
    Hudson RW; Lochnan HA; Danby FW; Margesson LJ; Strang BK; Kimmett SM
    Fertil Steril; 1990 Dec; 54(6):1065-71. PubMed ID: 2174005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal ovarian function in a mild form of late-onset 3 beta-hydroxysteroid dehydrogenase deficiency.
    Medina M; Herrera J; Flores M; Martin O; Bermúdez JA; Zárate A
    Fertil Steril; 1986 Dec; 46(6):1021-5. PubMed ID: 3023147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women.
    Rittmaster RS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1985 Sep; 61(3):462-6. PubMed ID: 2991319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women.
    Diamond MP; Grainger DA; Laudano AJ; Starick-Zych K; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Apr; 72(4):883-7. PubMed ID: 1826009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.